why choose us

First received: July 06, 2023

Clinical Trial: HYPEROXIA Responses and ROS

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Cerebrovascular Disorders

Study Type: INTERVENTIONAL


Official Title: Human Cerebral Blood Flow Regulation: Sex, Mechanism, and Stress Differences

Brief Summary: 30 participants (15 males and 15 females) who are ?18 - ? 40 years old and considered healthy will be enrolled into this study to test the role of reactive oxygen species (ROS) in regulating cerebral blood flow (CBF).Participants can expect to be on study for 2 study visits over a 6 month period.

Read more